ABVC BioPharma, Inc.
ABVC
$1.33
$0.021.53%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -196.37% | -61.30% | -11.47% | 43.49% | 66.92% |
| Total Depreciation and Amortization | 127.51% | 151.22% | -75.33% | -69.37% | -55.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 295.57% | 52.46% | 19.86% | -43.18% | -69.38% |
| Change in Net Operating Assets | -698.65% | -50.62% | -47.31% | 1.59% | -171.88% |
| Cash from Operations | -139.80% | -65.07% | -47.60% | 29.79% | 61.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -389.89% | 58.95% | 100.00% |
| Cash from Investing | -- | -- | -389.89% | 61.02% | 100.00% |
| Total Debt Issued | 1,381.67% | 138.91% | -99.47% | -60.43% | 104.19% |
| Total Debt Repaid | -206.23% | -53.83% | -68.52% | -146.38% | -106.65% |
| Issuance of Common Stock | 209.78% | 339.12% | 326.17% | 179.25% | 32.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -134.66% | -100.00% | 17.82% | -79.59% | -86.44% |
| Cash from Financing | 160.33% | 134.16% | 127.19% | -23.70% | -42.59% |
| Foreign Exchange rate Adjustments | 92.77% | 182.11% | 105.92% | 13.99% | -97.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -715.51% | 215.17% | 123.95% | 66,620.00% | 108.88% |